Pathogenic KIF1A variants differentially disrupt axonal trafficking and impede synaptic development
Journal of Cell Biology · 2026
DOI: 10.1083/jcb.202601034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, 2026. Verfasst von Jayne Aiken und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Kinesins, Synapses, Axons, Axonal Transport. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
The nervous system relies on billions of neurons connected through trillions of synapses to support vital functions. Despite the importance of this synaptic network, cellular mechanisms dictating synapse formation during human neurodevelopment remain unclear. Long-distance trafficking by the microtubule motor KIF1A is crucial for synaptogenesis and downstream synapse maintenance. Mutations in KIF1A cause KIF1A-associated neurological disorder (KAND). We employed isogenic gene-edited human-induced pluripotent stem cell -derived neurons to assess the effects of disparate pathogenic mutations in KIF1A on synaptic trafficking and function. Null (p.C92*) and hypoactive (p.P305L) mutations delay neurite outgrowth, mislocalize synaptic cargoes, and decrease synapse density. Conversely, a hyperactive (p.R350G) mutation supports neurite outgrowth but causes aberrant motility of synaptic vesicle precursors and deficits in microtubule-dependent presynaptic patterning. Functional analysis of neuronal activity reveals delayed synaptic maturation in loss-of-function mutations (p.P305L, p.C92*) and precocious activity in the hyperactive p.R350G mutation. These data provide insights into how KIF1A mutations with distinct molecular-level impacts lead to significant downstream synaptic deficits in human neurons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
- Neuroscience Graduate Group, University of Pennsylvania Perelman School of Medicine , Philadelphia, PA, USA.
- Center for Epilepsy and Neurodevelopmental Disorders (ENDD), University of Pennsylvania Perelman School of Medicine , Philadelphia, PA, USA.
- Biochemistry, Biophysics, and Chemical Biology Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- Pennsylvania Muscle Institute, University of Pennsylvania Perelman School of Medicine , Philadelphia, PA, USA.
ORCID-Profile: Jayne Aiken, Carris Borland, Nicolas Marotta, Benjamin L Prosser, Erika L F Holzbaur
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Aiken, J., Borland, C., Marotta, N., Prosser, B. L., & Holzbaur, E. L. F. (2026). Pathogenic KIF1A variants differentially disrupt axonal trafficking and impede synaptic development. Journal of Cell Biology. https://doi.org/10.1083/jcb.202601034
Vancouver
Aiken J, Borland C, Marotta N, Prosser BL, Holzbaur ELF. Pathogenic KIF1A variants differentially disrupt axonal trafficking and impede synaptic development. Journal of Cell Biology. 2026. doi:10.1083/jcb.202601034
BibTeX
@article{Aiken2026,
author = {Aiken, Jayne and Borland, Carris and Marotta, Nicolas and Prosser, Benjamin L and Holzbaur, Erika L F},
title = {Pathogenic KIF1A variants differentially disrupt axonal trafficking and impede synaptic development},
journal = {Journal of Cell Biology},
year = {2026},
doi = {10.1083/jcb.202601034}
}
EUVIMED